Analytical chemistry

Minister Champagne announces appointments to the Standards Council of Canada's Governing Council

Retrieved on: 
Monday, February 5, 2024

OTTAWA, ON, Feb. 5, 2024 /CNW/ - Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced recent appointments to the Standards Council of Canada's (SCC) Governing Council.

Key Points: 
  • OTTAWA, ON, Feb. 5, 2024 /CNW/ - Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced recent appointments to the Standards Council of Canada's (SCC) Governing Council.
  • He has been involved in standards development since 1984 in information technologies engineering and, more recently, biodigital convergence.
  • "These appointments will enhance the SCC's ability to continue to be a leader in the global standards industry.
  • – The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry
    Follow Canada Business on social media for business-related news: (X) Twitter , Facebook , Instagram

Dr. Kaveh Kahen, Appointed President at Phenomenex

Retrieved on: 
Thursday, February 1, 2024

TORRANCE, Calif., Feb. 1, 2024 /PRNewswire/ -- Phenomenex Inc., a global leader in the research and manufacturing of advanced separation science and technologies, proudly announces Dr. Kaveh Kahen's appointment as the company's President.

Key Points: 
  • TORRANCE, Calif., Feb. 1, 2024 /PRNewswire/ -- Phenomenex Inc., a global leader in the research and manufacturing of advanced separation science and technologies, proudly announces Dr. Kaveh Kahen's appointment as the company's President.
  • Dr. Kahen returns to the Danaher Life Sciences platform with a wealth of experience.
  • He began his career at SCIEX and was responsible for designing and developing novel technologies and instruments.
  • Kaveh is renowned for driving profitable growth in the highly competitive life sciences, analytical testing, and lab equipment markets.

Dr. Kaveh Kahen, Appointed President at Phenomenex

Retrieved on: 
Thursday, February 1, 2024

TORRANCE, Calif., Feb. 1, 2024 /PRNewswire/ -- Phenomenex Inc., a global leader in the research and manufacturing of advanced separation science and technologies, proudly announces Dr. Kaveh Kahen's appointment as the company's President.

Key Points: 
  • TORRANCE, Calif., Feb. 1, 2024 /PRNewswire/ -- Phenomenex Inc., a global leader in the research and manufacturing of advanced separation science and technologies, proudly announces Dr. Kaveh Kahen's appointment as the company's President.
  • Dr. Kahen returns to the Danaher Life Sciences platform with a wealth of experience.
  • He began his career at SCIEX and was responsible for designing and developing novel technologies and instruments.
  • Kaveh is renowned for driving profitable growth in the highly competitive life sciences, analytical testing, and lab equipment markets.

Plexium Announces Appointment of Michael Martin, Ph.D. as President and CEO

Retrieved on: 
Tuesday, January 16, 2024

SAN DIEGO, Jan. 16, 2024 /PRNewswire/ -- Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of Michael Martin, Ph.D. as President and Chief Executive Officer, and a member of the Board of Directors.

Key Points: 
  • SAN DIEGO, Jan. 16, 2024 /PRNewswire/ -- Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of Michael Martin, Ph.D. as President and Chief Executive Officer, and a member of the Board of Directors.
  • "I look forward to working with Mike to advance our clinical-stage pipeline and progressing more TPD programs against important cancer targets into the clinic."
  • I am excited to lead Plexium and continue to build a leading TPD company focused on improving patients' lives."
  • Dr. Martin joined Takeda in 2012 and prior to his most recent role, he was President of Takeda Ventures, Inc., Takeda's corporate venture capital company.

Aitia Appoints Drug R&D Executive Jean-Michel Gries as President & Chief Operating Officer

Retrieved on: 
Tuesday, September 19, 2023

SOMERVILLE, Mass., Sept. 19, 2023 /PRNewswire/ -- Aitia, the leader in the development and application of Causal AI and Digital Twins to discover and develop new drugs, today announced the appointment of Dr. Jean-Michel Gries as President & Chief Operating Officer.

Key Points: 
  • SOMERVILLE, Mass., Sept. 19, 2023 /PRNewswire/ -- Aitia, the leader in the development and application of Causal AI and Digital Twins to discover and develop new drugs, today announced the appointment of Dr. Jean-Michel Gries as President & Chief Operating Officer.
  • Jean-Michel is an accomplished senior life science executive with a track record of innovative drug discovery, translational medicine, and clinical development, combining the science and business of drug development.
  • He comes with a wealth of unique experience in drug R&D from big pharma, CROs, and small biotechs.
  • "I look forward to bringing my expertise and working alongside Colin and the teams towards revolutionizing drug discovery and development and ultimately improving the lives of patients."

Group14 Technologies Appoints Chemical Industry Leader Dr. Kim Ann Mink to its Board of Directors

Retrieved on: 
Thursday, September 14, 2023

WOODINVILLE, Wash., Sept. 14, 2023 /PRNewswire/ -- Group14 Technologies, the leading global manufacturer and supplier of advanced silicon battery technology, today announced the appointment of Dr. Kim Ann Mink to its board as its second independent director. Dr. Mink's leadership and expertise in the chemical industry will be a crucial asset to support Group14's growth as it scales its global manufacturing capacity in the US, Asia and Europe.

Key Points: 
  • After more than three decades in large multinational chemical companies, Dr. Mink brings a unique industry perspective to the board.
  • "Group14 has been successful in commercializing a proven, protected and scalable technology that addresses a real market need," Dr. Mink said.
  • "With unparalleled industry experience as a leader at some of the most successful global chemical companies, Kim Ann is a dynamic, energetic and highly sought-after advisor, which makes her the perfect addition to strengthen Group14's board," said Rick Luebbe, CEO and co-founder of Group14 Technologies.
  • "As we gear up for company growth, Kim Ann will be a critical voice on the Group14 board as we execute on our long-term vision for the electrification of everything."

Nevada Copper Appoints Dr. Elaine Dorward-King to its Board of Directors

Retrieved on: 
Tuesday, September 5, 2023

YERINGTON, Nev., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Nevada Copper Corp. (TSX: NCU) (OTC: NEVDF) (FSE: ZYTA) (“Nevada Copper” or the “Company”) is pleased to announce the appointment of Dr. Elaine Dorward-King to the Board of Directors of Nevada Copper effective September 1, 2023.

Key Points: 
  • YERINGTON, Nev., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Nevada Copper Corp. (TSX: NCU) (OTC: NEVDF) (FSE: ZYTA) (“Nevada Copper” or the “Company”) is pleased to announce the appointment of Dr. Elaine Dorward-King to the Board of Directors of Nevada Copper effective September 1, 2023.
  • Stephen Gill, Chairman of the Board of Directors of Nevada Copper, stated, “We are thrilled that Elaine has chosen to join Nevada Copper’s Board, adding her extensive history of leadership and achievements in sustainable development to our team.
  • Elaine joins Nevada Copper at a crucial time in the development cycle as we focus on and implement ESG initiatives through the restart and ramp up to sustained underground operations and further through the development of the open pit project.
  • Prior to that she held various leadership roles focused on environmental and sustainability programs for companies in the mining, environmental and chemical sectors.

Citryll Announces Appointments of Eduardo Bravo as CEO and Tim Schenk as CBO

Retrieved on: 
Tuesday, August 29, 2023

Citryll , a clinical-stage biotech company developing first-in-class therapeutics to treat immune-mediated inflammatory diseases, today announced the appointment of Eduardo Bravo as Chief Executive Officer.

Key Points: 
  • Citryll , a clinical-stage biotech company developing first-in-class therapeutics to treat immune-mediated inflammatory diseases, today announced the appointment of Eduardo Bravo as Chief Executive Officer.
  • In addition, Citryll has appointed Tim Schenk, Ph.D., as Chief Business Officer.
  • Dr. Schenk brings with him a broad background in business and commercial development across the life sciences industry.
  • As Mr. Bravo steps into the CEO role, Eric Meldrum, Ph.D., will fully resume his position as Chief Scientific Officer at Citryll.

Kanazawa University research: Researchers define a nanopipette fabrication protocol for high resolution cell imaging

Retrieved on: 
Tuesday, August 22, 2023

KANAZAWA, Japan, Aug. 22, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in Analytical Chemistry how to produce nanopipettes that reliably provide nanoscale resolution scanning ion conductance microscopy images of living cells.

Key Points: 
  • KANAZAWA, Japan, Aug. 22, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in Analytical Chemistry how to produce nanopipettes that reliably provide nanoscale resolution scanning ion conductance microscopy images of living cells.
  • Now researchers led by Yasufumi Takahashi at Kanazawa University's Nano LSI and Nagoya University have devised a protocol for reproducibly fabricating nanopipettes with the preferred geometry for high quality imaging.
  • Scanning ion conductance microscopy (SICM) uses a nanopipette to control the nanopipette-samples distance using an ion current as feedback signal.
  • Nanopipette Fabrication Guidelines for SICM Nanoscale Imaging, Analytical Chemistry August 20, 2023.

Kanazawa University research: Researchers define a nanopipette fabrication protocol for high resolution cell imaging

Retrieved on: 
Tuesday, August 22, 2023

KANAZAWA, Japan , Aug. 22, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in Analytical Chemistry how to produce nanopipettes that reliably provide nanoscale resolution scanning ion conductance microscopy images of living cells.

Key Points: 
  • KANAZAWA, Japan , Aug. 22, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in Analytical Chemistry how to produce nanopipettes that reliably provide nanoscale resolution scanning ion conductance microscopy images of living cells.
  • Now researchers led by Yasufumi Takahashi at Kanazawa University's Nano LSI and Nagoya University have devised a protocol for reproducibly fabricating nanopipettes with the preferred geometry for high quality imaging.
  • Scanning ion conductance microscopy (SICM) uses a nanopipette to control the nanopipette-samples distance using an ion current as feedback signal.
  • Nanopipette Fabrication Guidelines for SICM Nanoscale Imaging, Analytical Chemistry August 20, 2023.